Emergence client, Delivra Corp., is a Canadian company with an innovative technology for the transdermal delivery of bioactive compounds.
This is a full-time, permanent position as Analytical Research Scientist.
The candidate will support the development and utilization of methods for the quantification of drugs in biological matrices following the FDA’s Guideline for Bioanalytical Method Validation and complementary methods for the quantification of drug in finished formulations following ICH Guidelines Q2(R1) and Q1A(R2). The candidate may also be exposed to methods of organic synthesis and validation of compound structure and purity using nuclear magnetic resonance (NMR).
For further information, please CLICK HERE!
ABOUT DELIVRA CORP.
Delivra Corp. is a specialty biotechnology company having a proprietary transdermal delivery system platform that can shuttle pharmaceutical and natural molecules through the skin, in a targeted manner. Delivra manufactures and sells a growing line of natural topical creams with the proprietary transdermal delivery system platform under the LivReliefTMbrand, for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and under the LivSportTMbrand for sports performance.
LivReliefTMproducts are available in pharmacies, grocery chains, and independent health food stores across Canada, including, but not limited to, Shoppers Drug Mart, Walmart, Loblaw, Rexall, Pharmasave, London Drugs, and on-line at www.livrelief.com. In parallel with its consumer products business, Delivra also has a mandate to license its patent-pending, proprietary transdermal delivery technology platform to pharmaceutical companies globally, for the repurposing of pharmaceutical molecules transdermally to treat a broad range of conditions, along with licensing its over-the-counter products globally. Delivra is headquartered in Hamilton, Ontario and has a research and development laboratory in Charlottetown, PEI.